The chemical substance with the name "(2R,4R)-1-[[4,4-Difluoro-1-(4-methoxyphenyl)cyclohexyl]carbonyl]-N-(2,3-dihydro-2-oxo-1H-pyrrolo[3,2-b]pyridin-5-yl)-4-fluoro-2-pyrrolidinecarboxamide" and CAS number "2259641-59-1" is a complex organic compound characterized by its multi-cyclic structure and the presence of various functional groups. It features a pyrrolidine ring, which is a five-membered nitrogen-containing heterocycle, and incorporates a pyrrolo[3,2-b]pyridine moiety, indicating potential biological activity. The presence of difluoro and methoxy substituents suggests that the compound may exhibit unique electronic properties and lipophilicity, which can influence its pharmacokinetic profile. Additionally, the carbonyl and amide functionalities are indicative of potential interactions with biological targets, making it a candidate for pharmaceutical applications. The stereochemistry, denoted by the (2R,4R) configuration, implies specific spatial arrangements that can affect the compound's reactivity and biological activity. Overall, this compound's intricate structure and functional diversity suggest it may have significant implications in medicinal chemistry and drug development.

(2R,4R)-1-[[4,4-Difluoro-1-(4-methoxyphenyl)cyclohexyl]carbonyl]-N-(2,3-dihydro-2-oxo-1H-pyrrolo[3,2-b]pyridin-5-yl)-4-fluoro-2-pyrrolidinecarboxamide

2259641-59-1: The chemical substance with the name "(2R,4R)-1-[[4,4-Difluoro-1-(4-methoxyphenyl)cyclohexyl]carbonyl]-N-(2,3-dihydro-2-oxo-1H-pyrrolo[3,2-b]pyridin-5-yl)-4-fluoro-2-pyrrolidinecarboxamide" and CAS number "2259641-59-1" is a complex organic compound characterized by its multi-cyclic structure and the presence of various functional groups. It features a pyrrolidine ring, which is a five-membered nitrogen-containing heterocycle, and incorporates a pyrrolo[3,2-b]pyridine moiety, indicating potential biological activity. The presence of difluoro and methoxy substituents suggests that the compound may exhibit unique electronic properties and lipophilicity, which can influence its pharmacokinetic profile. Additionally, the carbonyl and amide functionalities are indicative of potential interactions with biological targets, making it a candidate for pharmaceutical applications. The stereochemistry, denoted by the (2R,4R) configuration, implies specific spatial arrangements that can affect the compound's reactivity and biological activity. Overall, this compound's intricate structure and functional diversity suggest it may have significant implications in medicinal chemistry and drug development.

<p>Ep300/CREBBP-IN-2: Potent, oral Ep300 &amp; CREBBP inhibitor; IC50s: 0.052μM &amp; 0.148μM; cancer research.</p>

CAS 2259641-59-1

(2R,4R)-1-[[4,4-Difluoro-1-(4-methoxyphenyl)cyclohexyl]carbonyl]-N-(2,3-dihydro-2-oxo-1H-pyrrolo[3,2-b]pyridin-5-yl)-4-fluoro-2-pyrrolidinecarboxamide

Ep300/CREBBP-IN-2

Ref: TM-T73921